The University of Chicago Header Logo

Connection

Jonathan Moss to Disease Progression

This is a "connection" page, showing publications Jonathan Moss has written about Disease Progression.
Connection Strength

0.181
  1. The µ-opioid receptor in cancer progression: is there a direct effect? Anesthesiology. 2012 Apr; 116(4):940-5.
    View in: PubMed
    Score: 0.074
  2. The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation. Anesth Analg. 2011 Mar; 112(3):558-67.
    View in: PubMed
    Score: 0.067
  3. The Mu opioid receptor promotes opioid and growth factor-induced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer. PLoS One. 2014; 9(3):e91577.
    View in: PubMed
    Score: 0.021
  4. Overexpression of the µ-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis. Anesthesiology. 2012 Apr; 116(4):857-67.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.